AB Soft ii manual Fibromyalgia, Hiv/Aids

7.Schiffmann R, Kopp JB, Austin HA, III, Sabnis S, Moore DF, Weibel T, Balow JE, Brady RO. Enzyme replacement therapy in Fabry disease: a randomized controlled trial. JAMA 285(21): 2743-2749, 6/2001.

Fibromyalgia

1.Armstrong DG, Chappell AS, Le TK, Kajdasz DK, Backonja M, D'Souza DN, Russell JM. Duloxetine for the management of diabetic peripheral neuropathic pain: evaluation of functional outcomes. Pain Med 8(5): 410-418, 7/2007.

2.Arnold LM, Lu Y, Crofford LJ, Wohlreich M, Detke MJ, Iyengar S, Goldstein DJ. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arthritis Rheum 50(9): 2974-2984, 9/2004.

3.Arnold LM, Rosen A, Pritchett YL, D'Souza DN, Goldstein DJ, Iyengar S, Wernicke JF. A randomized, double-blind, placebo- controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder. Pain 119(1-3): 5-15, 12/2005.

4.Arnold LM, Pritchett YL, D'Souza DN, Kajdasz DK, Iyengar S, Wernicke JF. Duloxetine for the treatment of fibromyalgia in women: pooled results from two randomized, placebo- controlled clinical trials. J Womens Health (Larchmt ) 16(8): 1145-1156, 10/2007.

5.Arnold LM, Goldenberg DL, Stanford SB, Lalonde JK, Sandhu HS, Keck PE, Welge JA, Bishop F, Stanford KE, Hess EV, Hudson JI. Gabapentin in the treatment of fibromyalgia - A randomized, double-blind, placebo-controlled, multicenter trial. Arthritis and Rheumatism 56(4): 1336-1344, 4/2007.

6.Dungey J, Arnold L, Pritchett Y, Robinson M, D'Souza D, Wernicke J. PR_186: Duloxetine in the Treatment of Fibromyalgia in Women: Results From 2 Clinical Trials. Archives of Physical Medicine and Rehabilitation 87(11): e36, 11/2006.

7.Russell IJ, Mease PJ, Smith TR, Kajdasz DK, Wohlreich MM, Detke MJ, Walker DJ, Chappell AS, Arnold LM. Efficacy and

safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6- month, randomized, double-blind, placebo-controlled, fixed- dose trial. Pain 136(3): 432-444, 6/2008.

8.Rutledge DN, Jones CJ. Effects of topical essential oil on exercise volume after a 12-week exercise program for women with fibromyalgia: A pilot study. Journal of Alternative and Complementary Medicine 13(10): 1099-1106, 12/2007.

HIV/AIDS

1.Breitbart W, McDonald MV, Rosenfeld B, Passik SD, Hewitt D, Thaler H, Portenoy RK. Pain in ambulatory AIDS patients. I: Pain characteristics and medical correlates. Pain 68(2-3): 315-321, 12/1996.

2.Breitbart W, Rosenfeld BD, Passik SD, McDonald MV, Thaler H, Portenoy RK. The undertreatment of pain in ambulatory AIDS patients. Pain 65(2-3): 243-249, 5/1996.

3.Breitbart W, Rosenfeld B, Passik S, Kaim M, Funesti-Esch J, Stein K. A comparison of pain report and adequacy of analgesic therapy in ambulatory AIDS patients with and without a history of substance abuse. Pain 72(1-2): 235-243, 8/1997.

4.Breitbart W, Passik S, McDonald MV, Rosenfeld B, Smith M, Kaim M, Funesti-Esch J. Patient-related barriers to pain management in ambulatory AIDS patients. Pain 76(1-2): 9-16, 5/1998.

5.Griswold GA, Evans S, Spielman L, Fishman B. Coping strategies of HIV patients with peripheral neuropathy. AIDS Care 17(6): 711-720, 8/2005.

6.Hoyt MJ, Nokes K, Newshan G, Staats JA, Thorn M. The effect of chemical dependency on pain perception in persons with AIDS. J Assoc Nurses AIDS Care 5(3): 33-38, 5/1994.

7.Larue F, Fontaine A, Colleau SM. Underestimation and undertreatment of pain in HIV disease: multicentre study. BMJ 314(7073): 23-28, 1/1997.

33 34